Sarepta Therapeutics | Ex: BioAgilytix Labs
Ph.D. pharmacology and drug discovery scientist with deep expertise in vitro assay development, in vivo pharmacology, oxidative stress biology, translational pharmacology, biomarker strategy, and genetic medicines. Proven experience advancing RNA therapeutics through target validation and mechanism-of-action studies.
Sarepta Therapeutics
Led scientific strategy for RNA and gene-therapy programs, integrating NGS, molecular, protein, and clinical data to evaluate MOA, target engagement, efficacy, and safety. Directed NGS studies, established biomarker frameworks, and developed advanced disease models.
BioAgilytix Labs
Directed assay development, qualification, and execution of RT-qPCR-based molecular assays and high-throughput workflows to support biomarker analysis and therapeutic assessment. Provided scientific leadership for assay optimization and troubleshooting.
Olix Pharmaceuticals
Led development and execution of disease-relevant in vitro and in vivo model pharmacology to evaluate GalNAc-siRNA therapeutic candidates. Designed cell-based screening strategies and conducted proof-of-concept studies.
Boston University School of Medicine
Conducted translational research investigating liver, cardiovascular, and neurological disease biology using gene modulation approaches. Utilized shRNA-mediated gene silencing and produced AAV vectors for gene modulation studies.
Hourly rate
$600